Skip to main content
Fig. 6 | Skeletal Muscle

Fig. 6

From: ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets

Fig. 6

AMI regulates the naive CD4 + T cell differentiation into Th17 in vitro. Naive CD4 + T cells were isolated from spleen and then were induced to differentiate into Th17 under the Th17 differentiation condition. (A) Th17 subset detected by flow cytometry (B) mRNA expression level of IL-17 A detected by qRT-PCR (C) protein level of p-STAT3 detected by WB. *P < 0.05, **P < 0.01. ***P < 0.001, experiments were repeated twice

Back to article page